
zzso patients with zzso zzso zzso are frequently excluded from cancer therapy trials, treated zzso or not treated at zzso The average survival in elderly patients is zzso zzso The goal of the present study was to evaluate the efficacy of different treatment options in terms of survival in an elderly population affected with zzso 

About 34 Patients with primary zzso zzso aged 65 or higher were included in this zzso All patients underwent zzso and tumor mass zzso After surgery they received radiation therapy, chemotherapy and zzso in different zzso 

zzso median survival was zzso months with one patient still alive at 35 zzso Survival was longer for patients who underwent total zzso instead of partial (13 months vs 4 months, zzso If total zzso zzso was used a further survival advantage was obtained (16 months for zzso zzso 9 months for zzso zzso zzso Where a second surgical intervention was performed median survival was 21 months zzso Survival according to zzso therapy has been 21 months zzso chemotherapy, zzso 18 months zzso zzso and 7 months zzso zzso 

We think that single zzso factor such as age should be not a reason for zzso 

